Amphastar Pharmaceuticals, Inc. Deferred Revenue
Amphastar Pharmaceuticals, Inc. (AMPH) had Deferred Revenue of $830.00 thousand as of 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Balance Sheet › Liabilities
us-gaap:DeferredRevenueCurrent · last filed 2017-03-15
- 2016-09-30: Deferred Revenue, Current $830.00K.
- 2016-06-30: Deferred Revenue, Current $1.66M.
- 2016-03-31: Deferred Revenue, Current $643.00K.
- 2015-12-31: Deferred Revenue, Current $643.00K.
| Period end | Deferred Revenue, Current |
|---|---|
| 2016-09-30 | $830.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.66M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $643.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $643.00K 10-K · filed 2017-03-15 |
| 2015-09-30 | $643.00K 10-Q · filed 2015-11-13 |
| 2014-12-31 | $14.01M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |